Weng Dan bought GYRE
August 18, 2025 · Form 4 insider transaction
Weng Dan bought 52,000 shares of Gyre Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 8 days after the transaction.
Direction
Acquired (buy-side)
Shares
52,000
Price
$0.00
Total value
N/A
InsiderWeng Dan
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateAugust 18, 2025
Filing dateAugust 26, 2025
Shares owned after52,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents a right to purchase a total of 52,000 shares of the Issuer's common stock, which will vest in 36 equal monthly installments through August 18, 2028, subject to the Reporting Person's continued service to the Issuer through each vesting date.